先進導管消融術的開發平台(管線):開發階段，市場區隔，地區和國家，法規途徑，主要企業(2024年版)

先進的消融導管利用了標準消融導管以外的特性和方法。先進的消融導管包括灌注尖端射頻消融導管、冷凍消融導管和雷射消融導管。

本報告提供先進導管消融術市場相關調查，提供產品概要與正在開發的開發中產品趨勢，各種處於開發階段的產品的比較分析和進行中的臨床試驗相關資訊，參與企業的最近趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

• 先進導管消融術概要

第3章 開發中的產品

• 先進導管消融術 - 各開發階段平台產品
• 先進導管消融術 - 各市場區隔開發中產品
• 先進導管消融術 - 各地區開發中產品
• 先進導管消融術 - 各法規途徑開發中產品
• 先進導管消融術 - 估計核准日開發中產品
• 先進導管消融術 - 進行中的臨床試驗

第4章 先進導管消融術- 各公司正在開發的開發中產品

• 先進導管消融術企業- 各開發階段的開發中產品
• 先進導管消融術- 各開發階段的開發中產品

第5章 先進導管消融術的企業和產品概要

• Apama Medical Inc
• Biosense Webster Inc
• Boston Scientific Corp
• CardioFocus Inc
• CathRx Ltd
• Cibiem, Inc.
• CryoTherapeutics SA
• Ethicon US LLC
• Farapulse Inc
• Japan Lifeline Co Ltd
• Medlumics SL
• MicroPort Scientific Corp
• Shanghai HeartCare Medical Technology Co Ltd
• St. Jude Medical LLC
• Stereotaxis Inc
• Vanderbilt University

第6章 先進導管消融術-最近的趨勢

第7章 附錄

GlobalData's Medical Devices sector report, "Advanced Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Advanced Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An advanced ablation catheter utilizes features and methods beyond those of standard ablation catheters. Advanced ablation catheters tracked are irrigated tip RF ablation catheters, cryoablation catheters, and laser ablation catheters.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Advanced Ablation Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Advanced Ablation Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Advanced Ablation Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Advanced Ablation Catheters Overview

3 Products under Development

• 3.1 Advanced Ablation Catheters - Pipeline Products by Stage of Development
• 3.2 Advanced Ablation Catheters - Pipeline Products by Segment
• 3.3 Advanced Ablation Catheters - Pipeline Products by Territory
• 3.4 Advanced Ablation Catheters - Pipeline Products by Regulatory Path
• 3.5 Advanced Ablation Catheters - Pipeline Products by Estimated Approval Date
• 3.6 Advanced Ablation Catheters - Ongoing Clinical Trials

4 Advanced Ablation Catheters - Pipeline Products under Development by Companies

• 4.1 Advanced Ablation Catheters Companies - Pipeline Products by Stage of Development
• 4.2 Advanced Ablation Catheters - Pipeline Products by Stage of Development

5 Advanced Ablation Catheters Companies and Product Overview

• 5.1 Apama Medical Inc Company Overview
  • 5.1.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Biosense Webster Inc Company Overview
  • 5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Boston Scientific Corp Company Overview
  • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 CardioFocus Inc Company Overview
  • 5.4.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 CathRx Ltd Company Overview
  • 5.5.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Cibiem, Inc. Company Overview
  • 5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 CryoTherapeutics SA Company Overview
  • 5.7.1 CryoTherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Ethicon US LLC Company Overview
  • 5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Farapulse Inc Company Overview
  • 5.9.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Japan Lifeline Co Ltd Company Overview
  • 5.10.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Medlumics SL Company Overview
  • 5.11.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 MicroPort Scientific Corp Company Overview
  • 5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Shanghai HeartCare Medical Technology Co Ltd Company Overview
  • 5.13.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 St. Jude Medical LLC Company Overview
  • 5.14.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Stereotaxis Inc Company Overview
  • 5.15.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Vanderbilt University Company Overview
  • 5.16.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

6 Advanced Ablation Catheters- Recent Developments

• 6.1 Jun 13, 2024: Medtronic Confirms Global Layoffs
• 6.2 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
• 6.3 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
• 6.4 May 16, 2024: Biosense Webster to Present Data from 42 Company-Sponsored or Funded Studies, Including PFA and RF Innovation, at Heart Rhythm Society Annual Meeting
• 6.5 May 14, 2024: CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
• 6.6 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
• 6.7 Apr 09, 2024: First Look at Data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF Platform for Atrial Fibrillation Presented at EHRA Congress
• 6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
• 6.9 Mar 04, 2024: Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
• 6.10 Jan 08, 2024: Stereotaxis Announces First Patients Successfully Treated using MAGiC Ablation Catheter
• 6.11 Dec 14, 2023: Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation
• 6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
• 6.13 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
• 6.14 Aug 23, 2023: Boston Scientific Obtains Pre-Market Approval (PMA) for POLARx FIT Cryoablation Balloon Catheter
• 6.15 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer